O

OrbusNeich Medical Group Holdings Ltd
HKEX:6929

Watchlist Manager
OrbusNeich Medical Group Holdings Ltd
HKEX:6929
Watchlist
Price: 3.61 HKD -2.17% Market Closed
Market Cap: 3B HKD

Intrinsic Value

The intrinsic value of one OrbusNeich Medical Group Holdings Ltd stock under the Base Case scenario is 6.2 HKD. Compared to the current market price of 3.61 HKD, OrbusNeich Medical Group Holdings Ltd is Undervalued by 42%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
6.2 HKD
Undervaluation 42%
Intrinsic Value
Price
O
Worst Case
Base Case
Best Case

Valuation History
OrbusNeich Medical Group Holdings Ltd

What is Valuation History?
Ask AI Assistant
What other research platforms think about OrbusNeich Medical Group Holdings Ltd?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is OrbusNeich Medical Group Holdings Ltd valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for OrbusNeich Medical Group Holdings Ltd.

Explain Valuation
Compare OrbusNeich Medical Group Holdings Ltd to

Fundamental Analysis

OrbusNeich Medical Group Holdings Ltd
Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about OrbusNeich Medical Group Holdings Ltd?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Revenue & Expenses Breakdown
OrbusNeich Medical Group Holdings Ltd

Balance Sheet Decomposition
OrbusNeich Medical Group Holdings Ltd

Current Assets 361.5m
Cash & Short-Term Investments 248.6m
Receivables 44.4m
Other Current Assets 68.5m
Non-Current Assets 69.6m
Long-Term Investments 14.9m
PP&E 27.6m
Intangibles 20m
Other Non-Current Assets 7.1m
Current Liabilities 30.7m
Accounts Payable 6.8m
Accrued Liabilities 13.2m
Other Current Liabilities 10.7m
Non-Current Liabilities 7m
Long-Term Debt 2.4m
Other Non-Current Liabilities 4.6m
Efficiency

Free Cash Flow Analysis
OrbusNeich Medical Group Holdings Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
OrbusNeich Medical Group Holdings Ltd

Revenue
168.7m USD
Cost of Revenue
-54.1m USD
Gross Profit
114.6m USD
Operating Expenses
-80.3m USD
Operating Income
34.3m USD
Other Expenses
6.4m USD
Net Income
40.7m USD
Fundamental Scores

Profitability Score
Profitability Due Diligence

OrbusNeich Medical Group Holdings Ltd's profitability score is 59/100. The higher the profitability score, the more profitable the company is.

Positive 3Y Average ROIC
Exceptional Gross Margin
Positive ROIC
Strong 3Y Average Gross Margin
59/100
Profitability
Score

OrbusNeich Medical Group Holdings Ltd's profitability score is 59/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

OrbusNeich Medical Group Holdings Ltd's solvency score is 99/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
99/100
Solvency
Score

OrbusNeich Medical Group Holdings Ltd's solvency score is 99/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
OrbusNeich Medical Group Holdings Ltd

Wall Street analysts forecast OrbusNeich Medical Group Holdings Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for OrbusNeich Medical Group Holdings Ltd is 6.73 HKD with a low forecast of 6.46 HKD and a high forecast of 7.14 HKD.

Lowest
Price Target
6.46 HKD
79% Upside
Average
Price Target
6.73 HKD
86% Upside
Highest
Price Target
7.14 HKD
98% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for OrbusNeich Medical Group Holdings Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one OrbusNeich Medical Group Holdings Ltd stock?

The intrinsic value of one OrbusNeich Medical Group Holdings Ltd stock under the Base Case scenario is 6.2 HKD.

Is OrbusNeich Medical Group Holdings Ltd stock undervalued or overvalued?

Compared to the current market price of 3.61 HKD, OrbusNeich Medical Group Holdings Ltd is Undervalued by 42%.

Back to Top